ÂÜÀòÂÒÂ×

Ms. Morris serves as Aqualung’s CFO, since October 2018. Prior to Aqualung, she served as the Chief Financial Officer of Cerecor from May 2015 through August 2018. While at Cerecor, she completed the Company’s IPO and raised over $28 million in financings, in-licensed and out-licensed key assets, and completed two corporate acquisitions. She was responsible for the Company’s financial and corporation operations, investor relations, and served as the board’s secretary. Prior to joining Cerecor, Ms. Morris was the sole proprietor of Mariam Morris CPA, a full-service tax, accounting, and business consulting firm, which she founded in January 2009 and operated until May 2015 where she served as an advisor to many private and public biotechnology companies. She served as the Chief Financial Officer of Sucampo Pharmaceuticals, Inc. from February 2004 to July 2009, where she completed the Company’s IPO and raised over $56 million in financings. From 1991 until 2001, Ms. Morris was and managing auditor for PricewaterhouseCoopers. Ms. Morris received her B.B.A. in Accounting from Texas Tech University and her M.S. in Taxation from Old Dominion University. Ms. Morris is a Certified Public Accountant in the State of Texas and a member of the TSCPA and AICPA.